Case Report: Untreatable Headache in a Child With Ventriculoperitoneal Shunt Managed by Use of New Non-invasive Intracranial Pressure Waveform

brain4care, a new Food and Drug Administration (FDA)-cleared non-invasive sensor that monitors intracranial pressure waveforms, was used in a 13-year-old girl who presented with untreatable headaches. The patient had a history of craniopharyngioma resection and a ventriculoperitoneal shunt placement...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in neuroscience 2021-02, Vol.15, p.601945
Main Authors: Paraguassu, Geraldo, Khilnani, Mark, Rabelo, Nicollas Nunes, Cobos, Luiza D'Ottaviano, Frigieri, Gustavo
Format: Article
Language:English
Subjects:
altered intracranial pressure
Asymptomatic
Case reports
Catheters
Cerebrospinal fluid
Compliance
craniopharyngioma
Guardians
Headache
Headaches
Heart rate
Hydrocephalus
Hypotheses
Intracranial pressure
Neoplasia
Neuroscience
non-invasive intracranial pressure monitor
Patients
Pituitary
Pressure
Sensors
untreatable headache
Ventriculoperitoneal shunt
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:brain4care, a new Food and Drug Administration (FDA)-cleared non-invasive sensor that monitors intracranial pressure waveforms, was used in a 13-year-old girl who presented with untreatable headaches. The patient had a history of craniopharyngioma resection and a ventriculoperitoneal shunt placement 7 years prior to the use of the device. Secondary obstructive hydrocephalus was also a present factor in the case. The hypothesis was that due to the hydrocephalus, the child presented chronic headaches and needed constant readjustment into the ventriculoperitoneal shunt to regulate the cerebrospinal fluid inside her ventricles in order to control the patient's intracranial pressure (ICP). The device was chosen considering the risks to submit a patient into the regular invasive method to measure ICP. It was identified that the device could also indicate altered intracranial compliance due to the ratio between the P1 and P2 amplitudes (P2/P1 ratio > 1).
ISSN:1662-4548
1662-453X
1662-453X
DOI:10.3389/fnins.2021.601945